![](/img/cover-not-exists.png)
Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2‐Positive Early Stage Breast Cancer: A Single Center Experience
Singh, Jasmeet C., Mamtani, Anita, Barrio, Andrea, Morrow, Monica, Sugarman, Steven, Jones, Lee W., Yu, Anthony F., Argolo, Daniel, Smyth, Lilian M., Modi, Shanu, Schweber, Sarah, Boafo, Camilla, PatiVolume:
22
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2016-0268
Date:
February, 2017
File:
PDF, 166 KB
english, 2017